Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
→ Minerva Neurosciences saw its shares $NERV jump on Thursday, after it announced revised terms to its collaboration with J&J on its orexin 2 receptor …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
